Italian guidelines for the treatment of type 2 diabetes
doi: 10.3892/mmr.2020.11469 105 LiYHuangHLiuBZhangYPanXYuXYet al
Estos medicamentos tienen el potencial de producir una prdida de peso considerable, especialmente en el primer ao, afirma Juan Franco , primer autor de una de las revisiones e investigador de la Universidad Heinrich Heine de Dsseldorf, Alemania, vinculado a la Red Cochrane Iberoamericana
Wegovy's carve-out is cardiovascular, not sleep apnea
If youre feeling extra tired while taking a GLP-1 drug or if you notice any other new or worsening symptoms talk with your healthcare provider
Several candidate compounds are currently known to favorably influence sphingolipid metabolism, thus becoming therapeutic drugs ( Table 1 )